Antidepressant & Antipsycotic Drug Response

See Cepmed’s Personalized Medicine Portal for more information about this test

Read More

Select your province to learn about access to testing & services in your area.

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada.  Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program

Overview

Cytochrome P450 liver enzymes CYP2D6 and CYP2C19 are involved in the metabolism of many psychiatric drugs including antidepressants and antipsychotics. Variations in CYP2D6 or CYP2C19 genes may affect an individual’s response to particular antidepressant or antipsychotic drugs. Genetic testing may inform drug selection and enable optimization of treatment. Follow the Read More button above to learn more.

This type of genetic testing is not readily available in Canada. Discuss this test with your physician if you feel it could be beneficial for you.

Public Providers

Resources

Private Laboratories*

*U.S. laboratories listed are certified by Centers for Medicare & Medicaid Service (CMS) CLIA Program